newsfilter
← Latest News
Business Wire·

Turn Therapeutics to Present at Jefferies Global Healthcare Conference 2026

  • Turn Therapeutics Inc. (NASDAQ: TTRX) CEO Bradley Burnam will present at the Jefferies Global Healthcare Conference in New York City on June 4, 2026, from 9:55 AM to 10:25 AM EDT.
  • A live webcast of the presentation will be available on the company's Investor Relations website, with a replay accessible for approximately six months post-event.
  • The company's lead investigational therapy, GX-03, is a first-in-class, non-systemic topical inhibitor targeting IL-36 & IL-31 cytokines for moderate-to-severe atopic dermatitis.
  • GX-03 is designed to address the inflammatory cascade upstream at IL-36 & the itch signaling downstream at IL-31.
  • Topline results from the Phase 2 randomized controlled trial for GX-03 are expected in mid-2026.